Your browser doesn't support javascript.
loading
Diferencias entre agalsidasa alpha y agalsidasa Beta en el tratamiento de la enfermedad de Fabry / Differences between agalsidase alpha and agalsidase Beta in the treatment of Fabry disease
Pérez López, Jordi; Domínguez Gil-Hurlé, Alfonso; López Rodríguez, Mónica.
Affiliation
  • Pérez López, Jordi; Hospital Vall d’Hebron. Unidad de Enfermedades Minoritarias. Barcelona. España
  • Domínguez Gil-Hurlé, Alfonso; Universidad de Salamanca. Departamento de Farmacia y Tecnología Farmacéutica. Salamanca. España
  • López Rodríguez, Mónica; Hospital Central de la Cruz Roja. Servicio de Medicina Interna. Madrid. España
Med. clín (Ed. impr.) ; 149(6): 270-270, sept. 2017.
Article in Spanish | IBECS | ID: ibc-166558
Responsible library: ES1.1
Localization: BNCS
RESUMEN
No disponible
Subject(s)
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Fabry Disease / Beta-Galactosidase / Alpha-Galactosidase Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2017 Document type: Article Institution/Affiliation country: Hospital Central de la Cruz Roja/España / Hospital Vall d’Hebron/España / Universidad de Salamanca/España
Search on Google
Add to My VHL
Print
XML

Collection: National databases / Spain Database: IBECS Main subject: Fabry Disease / Beta-Galactosidase / Alpha-Galactosidase Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2017 Document type: Article Institution/Affiliation country: Hospital Central de la Cruz Roja/España / Hospital Vall d’Hebron/España / Universidad de Salamanca/España